93.833: Supporting and Maintaining a Surveillance System for Chronic Kidney Disease (CKD) in the United States

93.833

Active

Centers for Disease Control and Prevention (CDC) [HHS]

Sept. 2, 2022

Sept. 2, 2022

This award will build upon previous work to continue developing, supporting and enhancing the CKD Surveillance System in the United States, to monitor the burden and trends of CKD and its risk factors over time, and monitor and evaluate trends in achieving Healthy People 2020 objectives.

B - Cooperative Agreements

• Public nonprofit organizations • Private nonprofit organizations • For profit organizations • Small, minority, and women-owned businesses • Universities • Colleges • Research institutions • Hospitals • Community-based organizations • Faith-based organizations • Indian/Native American Tribal Governments (Federally Recognized) • Indian/Native American Tribal Governments (other than Federally recognized) • Indian/Native American Tribally Designated Organizations State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Note: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

The general public will benefit from the objectives of this program. Kidney diseases are the ninth leading cause of death in the United States and more than 1 of 10 US adults may have CKD. The CKD Surveillance System is intended to raise awareness about CKD and its risk factors, promote early diagnosis, and improve outcomes for those living with CKD.

93.283 - Centers for Disease Control and Prevention Investigations and Technical Assistance

https://sam.gov/fal/6cdd4c9249a546379df10ee54ef9ddfd/view